MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and/or cholangiocarcinoma

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Voigtländer, Torsten ^a   Gupta, Shashi K ^a   Thum, Sabrina ^a   Fendrich, Jasmin ^a   Manns, Michael P ^a   Lankisch, Tim O ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; MICRORNA; MICRORNA 122; MICRORNA 126; MICRORNA 128; MICRORNA 26A; MICRORNA 30B; MICRORNA 412; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; BILE DUCT CARCINOMA; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; BILE; BILE DUCT TUMOR; BLOOD; CASE CONTROL STUDY; METABOLISM; SCLEROSING CHOLANGITIS;

BILE; BILE DUCT NEOPLASMS; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; HUMANS; MICRORNAS;

EID: 84947279867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139305     Document Type: Article

References (41)

1. Weismüller TJ, Lankisch TO. Medical and endoscopic therapy of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2011; 25: 741-752. doi: 10.1016/j.bpg.2011.10.003 PMID: 22117639
2. Trauner M, Halilbasic E, Baghdasaryan A, Moustafa T, Krones E, Fickert P, et al. Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment. Dig Dis 2012; 30 Suppl 1:39-47. doi: 10.1159/000341123 PMID: 23075867
3. Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol 2013; 59: 571-582. doi: 10.1016/j.jhep.2013.03.015 PMID: 23603668
4. Boberg KM, Lind GE. Primary sclerosing cholangitis and malignancy. Best Pract Res Clin Gastroenterol 2011; 25: 753-764. doi: 10.1016/j.bpg.2011.10.002 PMID: 22117640
5. de Valle MB, Björnsson E, Lindkvist B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 2012; 32:441-448. doi: 10.1111/j.1478-3231.2011. 02614.x PMID: 22098097
6. Karlsen TH, Vesterhus M, Boberg KM. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Aliment Pharmacol Ther 2014; 39: 282-301. doi: 10.1111/apt.12581 PMID: 24372568
7. Marin JJ, Bujanda L, Banales JM. MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol 2014; 30: 303-309. doi: 10.1097/MOG.0000000000000051 PMID: 24553410
8. Li L, Masica D, Ishida M, Tomuleasa C, Umegaki S, Kalloo AN, et al. Human bile contains microRNAladen extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology 2014; 60: 896-907. doi: 10.1002/hep.27050 PMID: 24497320
9. Lankisch TO, Voigtländer T, Manns MP, Holzmann A, Dangwal S, Thum TMicroRNAs in the bile of patients with biliary strictures after liver transplantation. Liver Transpl 2014; 20:673-678. doi: 10.1002/lt.23872 PMID: 24648209
10. Farid WR, Verhoeven CJ, de Jonge J, Metselaar HJ, Kazemier G, van der Laan LJ The Ins and Outs of MicroRNAs as Biomarkers in Liver Disease and Transplantation. Transpl Int 2014. doi: 10.1111/tri. 12379 PMID: 24963540
11. Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 2013; 10: 542-552. doi: 10.1038/nrgastro.2013.87 PMID: 23689081
12. Munoz-Garrido P, García-Fernández de Barrena M, Hijona E, Carracedo M, Marín JJ, Bujanda L, et al. MicroRNAs in biliary diseases. World J Gastroenterol 2012; 18: 6189-6196. doi: 10.3748/wjg.v18.i43. 6189 PMID: 23180938
13. Williamson KD, Chapman RW. Primary sclerosing cholangitis. Dig Dis 2014; 32: 438-445. doi: 10.1159/000358150 PMID: 24969292
14. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 2013; 145: 521-536. doi: 10.1053/j.gastro.2013.06.052 PMID: 23827861
15. Lankisch TO, Metzger J, Negm AA, Vosskuhl K, Schiffer E, Siwy J, et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 2011; 53: 875-884. doi: 10.1002/hep.24103 PMID: 21374660
16. Metzger J, Negm AA, Plentz RR, Weismüller TJ, Wedemeyer J, Karlsen TH, et al. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut 2013; 62: 122-130. doi: 10.1136/gutjnl-2012-302047 PMID: 22580416
17. Toffanin S, Sia D, Villanueva A. MicroRNAs: new ways to block tumor angiogenesis? J Hepatol 2012; 57: 490-491. doi: 10.1016/j.jhep.2012.06.005 PMID: 22691573
18. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012; 56: 389-396. doi: 10.1016/j.jhep.2011.08.008 PMID: 21888875
19. Yang H, Li TW, Peng J, Tang X, Ko KS, Xia M, et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology 2011; 1: 378-388.
20. Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, et al. MiR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010; 52: 2148-2157. doi: 10.1002/hep.23915 PMID: 20979124
21. Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncol Rep 2014; 3: 1157-1164.
22. Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y, et al. Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann Surg Oncol 2012; 19 Suppl 3: S509-517. doi: 10.1245/s10434-011-1999-2 PMID: 21845495
23. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, et al. MicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 2013; 132: 2479-2491. doi: 10.1002/ijc. 27949 PMID: 23169479
24. Salvucci O, Jiang K, Gasperini P, Maric D, Zhu J, Sakakibara S, et al. MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. Haematologica 2012; 97: 818-826. doi: 10.3324/haematol.2011.056945 PMID: 22271895
25. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008; 373: 607-612. doi: 10.1016/j.bbrc.2008.06.090 PMID: 18602365
26. Tomasetti M, Nocchi L, Staffolani S, Manzella N, Amati M, Goodwin J, et al. MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with the Mitochondrial Function. Antioxid Redox Signal 2014. doi: 10.1089/ars.2013.5215 PMID: 24444362
27. Miyaaki H, Ichikawa T, Kamo Y, Taura N, Honda T, Shibata H, et al. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. Liver Int 2014; 34: e302-307. doi: 10.1111/liv.12429 PMID: 24313922
28. Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. J Med Virol 2014; 86: 1507-1514. doi: 10.1002/jmv.23987 PMID: 24895202
29. Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol 2014; 49: 589-593. doi: 10.1007/s00535-014-0932-4 PMID: 24531873
30. Dong J, Sui L, Wang Q, Chen M, Sun H. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1. Mol Med Rep 2014; 10: 1426-1432. doi: 10.3892/mmr.2014.2335 PMID: 24939702
31. Gentilin E, Tagliati F, Filieri C, Molè D, Minoia M, Rosaria Ambrosio M, et al. MiR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ. Endocrinology 2013; 154: 1690-1700. doi: 10.1210/en.2012-2070 PMID: 23525216
32. Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY, Cui YM, et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. BMC Syst Biol 2013; 7: 104.
33. Bessho K, Shanmukhappa K, Sheridan R, Shivakumar P, Mourya R, Walters S, et al. Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia. J Pathol 2014; 232: 415-427.
34. Skipworth JR, Keane MG, Pereira SP. Update on the management of cholangiocarcinoma. Dig Dis 2014; 32: 570-578. doi: 10.1159/000360507 PMID: 25034290
35. Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, et al. Real-time PCRbased analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PloS One 2011; 6: e23584. doi: 10.1371/journal.pone.0023584 PMID: 21858175
36. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009; 114: 3872-3879. doi: 10.1182/blood-2009-06-229211 PMID: 19717645
37. Li X, Lu Y, Chen Y, Lu W, Xie X MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples. BMC Cancer 2013; 13: 216. doi: 10.1186/1471-2407-13-216 PMID: 23627607
38. Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2011; 137: 557-566. doi: 10.1007/s00432-010-0918-4 PMID: 20508945
39. Ward J, Kanchagar C, Veksler-Lublinsky I, Lee RC, McGill MR, Jaeschke H, et al. Circulating micro-RNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc Natl Acad Sci U S A 2014; 111: 12169-12174. doi: 10.1073/pnas.1412608111 PMID: 25092309
40. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012; 37:460-465. doi: 10.1016/j.tibs.2012.08.003 PMID: 22944280
41. Roest HP, Verhoeven CJ, van derLaan LJ. MicroRNAs in bile vesicles: Finding a trade-off for biomarker discovery. Hepatology 2014. doi: 10.1002/hep.27325 [Epub ahead of print]. PMID: 25048976